Literature DB >> 28315014

Association of native T1 times with biventricular function and hemodynamics in precapillary pulmonary hypertension.

Yin Yin Chen1,2,3, Hong Yun1,2,3, Hang Jin1,2,3, De Hong Kong4, Yu Liang Long5, Cai Xia Fu6, Shan Yang7,8,9, Meng Su Zeng10,11,12.   

Abstract

In precapillary pulmonary hypertension (PH) patients, we sought to (1) investigate the relationship between ventricular insertion point (VIP) T1 times, hemodynamic parameters, and biventricular function, and (2) determine the predictors of anterior and inferior VIP T1 time. Twenty-two patients with precapillary PH underwent 1.5-T cardiac MR, right heart catheterization (RHC), and echocardiography. A group of 10 healthy age- and sex-matched volunteers served as controls. Biventricular function, morphology and mass were obtained from short-axis cine images. Native T1 times at anterior, inferior VIP, septum and LV lateral wall were respectively derived from all subjects. Mixed venous oxygen saturation (SvO2) was the strongest hemodynamic parameters correlating with anterior (rp = -0.67, P = 0.001) and inferior VIP T1 time (rp = -0.81, P < 0.001). Elevated VIP T1 times were associated with reduced right ventricular (RV) ejection fraction, RV longitudinal and transverse motion, and increased RV end-diastolic and end-systolic volume index. LV diastolic function, quantified as mitral E velocity, was negatively correlated with anterior, inferior VIP (rp = -0.55, P = 0.01) and septal T1 times (rp = -0.50, P = 0.02), and positively correlated with RV systolic function and wall motion. In multivariate linear regression analyses, systolic eccentricity index (sEI) was the independent predictor of average VIPs T1 time (β= 0.47, P < 0.01), and remained significant correlation after adjustment of RHC and demographic parameters. In patients with precapillary PH, VIP T1 times are associated with biventricular function and hemodynamic parameters. Among all the parameters, sEI acts as a determinant of average VIPs T1 time.

Entities:  

Keywords:  Biventricular function; Native T1 time; Pulmonary hypertension; T1-mapping

Mesh:

Year:  2017        PMID: 28315014     DOI: 10.1007/s10554-017-1095-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  31 in total

1.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

Review 2.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

3.  Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension.

Authors:  Javier Sanz; Santo Dellegrottaglie; Mbabazi Kariisa; Roxana Sulica; Michael Poon; Thomas P O'Donnell; Davendra Mehta; Valentin Fuster; Sanjay Rajagopalan
Journal:  Am J Cardiol       Date:  2007-06-27       Impact factor: 2.778

4.  Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension.

Authors:  Yoshiki Motoji; Hidekazu Tanaka; Yuko Fukuda; Hiroyuki Sano; Keiko Ryo; Junichi Imanishi; Tatsuya Miyoshi; Takuma Sawa; Yasuhide Mochizuki; Kensuke Matsumoto; Noriaki Emoto; Ken-ichi Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-23       Impact factor: 2.357

Review 5.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

7.  RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension.

Authors:  Rebecca R Vanderpool; Michael R Pinsky; Robert Naeije; Christopher Deible; Vijaya Kosaraju; Cheryl Bunner; Michael A Mathier; Joan Lacomis; Hunter C Champion; Marc A Simon
Journal:  Heart       Date:  2014-09-11       Impact factor: 5.994

8.  Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis.

Authors:  Franck Thuny; Daniel Lovric; Frédéric Schnell; Cyrille Bergerot; Laura Ernande; Vincent Cottin; Geneviève Derumeaux; Pierre Croisille
Journal:  Radiology       Date:  2014-01-15       Impact factor: 11.105

9.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

10.  Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.

Authors:  Benjamin H Freed; Mardi Gomberg-Maitland; Sonal Chandra; Victor Mor-Avi; Stuart Rich; Stephen L Archer; E Bruce Jamison; Roberto M Lang; Amit R Patel
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

View more
  5 in total

1.  Diagnostic and prognostic value of right ventricular eccentricity index in pulmonary artery hypertension.

Authors:  Lili Wang; Xiaoling Chen; Ke Wan; Chao Gong; Weihao Li; Yuanwei Xu; Jie Wang; Juan He; Bi Wen; Yuchi Han; Rui Zeng; Yucheng Chen
Journal:  Pulm Circ       Date:  2020-04-09       Impact factor: 3.017

2.  Right ventricular septomarginal trabeculation hypertrophy is associated with disease severity in patients with pulmonary arterial hypertension.

Authors:  Yang Dong; Jiayu Sun; Dan Yang; Juan He; Wei Cheng; Ke Wan; Hong Liu; Andreas Greiser; Xiaoyue Zhou; Yuchi Han; Yucheng Chen
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-31       Impact factor: 2.357

3.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

Review 4.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

Review 5.  Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?

Authors:  Barbro Kjellström; Anthony Lindholm; Ellen Ostenfeld
Journal:  Curr Heart Fail Rep       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.